Pacemakers are essential in managing cardiac arrhythmias, improving patient outcomes by providing reliable heart rate regulation. The selection of pacemaker devices is influenced by multiple factors, including technical specifications, clinical needs, cost considerations, and procurement policies. Understanding these factors is critical for optimizing patient care and resource allocation. This study analyzes the procurement and application of single-chamber and dual-chamber pacemakers from different manufacturers in the Republic of Srpska. A comparative assessment was conducted by reviewing procurement records, device specifications, and institutional purchasing patterns. Key factors such as pricing, delivery times, and technological features were examined to determine their influence on institutional choices. The results reveal distinct manufacturer preferences across institutions. Medtronic pacemakers were widely selected for their advanced programming, long battery life, and remote monitoring capabilities. Boston Scientific’s dual-chamber devices gained traction due to their enhanced rate responsiveness and diagnostic tools. St. Jude Medical (Abbott) pacemakers were favored for their integrated safety features, while Biotronik provided a cost-effective alternative for institutions prioritizing affordability. Procurement trends indicate that both technological advancements and economic constraints shape institutional decisions. The findings suggest that while technical superiority is a major factor, financial and logistical considerations also play a crucial role. As pacemaker technology evolves, advancements such as AI-driven adaptive pacing, improved battery efficiency, and leadless designs are expected to influence future procurement strategies. A balanced approach, considering both innovation and cost-effectiveness, will be essential in optimizing pacemaker selection and improving patient care.